Rosa María Ayala

32PUBLICATIONS
179CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Diagnostic radiographyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 31, 2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|Jul 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

|May 07, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.

|Oct 31, 2025
Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis.

Alberto Blanco-Sánchez, Rosa Ayala, Gonzalo Carreño-Tarragona

|Oct 28, 2025
Optical genome mapping in myelofibrosis: enhancing prognostic accuracy through high-resolution genomic profiling.

Álvaro Díaz-González, Elvira Mora, Marta Garrote

Pageof 6

Frequent Collaborators

15 joint publications

Joaquín Martínez-López

10 joint publications

Gonzalo Carreño-Tarragona

6 joint publications

Juan-Carlos Hernández-Boluda

6 joint publications

Mar Tormo